🇺🇸 FDA
Pipeline program

Bacillus Clausii Multi ATB Resist

ENTER_L_01125

Approved small_molecule completed

Quick answer

Bacillus Clausii Multi ATB Resist for Diarrhea, Infantile is a Approved program (small_molecule) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).

Program details

Company
Sanofi Pasteur
Indication
Diarrhea, Infantile
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials